0001127602-18-012374.txt : 20180321 0001127602-18-012374.hdr.sgml : 20180321 20180321160156 ACCESSION NUMBER: 0001127602-18-012374 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180319 FILED AS OF DATE: 20180321 DATE AS OF CHANGE: 20180321 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROTHBLATT MARTINE A CENTRAL INDEX KEY: 0001106578 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 18704463 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2018-03-19 0001082554 UNITED THERAPEUTICS Corp UTHR 0001106578 ROTHBLATT MARTINE A C/O UNITED THERAPEUTICS CORPORATION 1040 SPRING STREET SILVER SPRING MD 20910 1 1 Chairman & CEO Common Stock 2018-03-19 4 M 0 21512 52.65 A 21652 D Common Stock 2018-03-19 4 S 0 21390 110.0254 D 262 D Common Stock 2018-03-19 4 S 0 122 111.6077 D 140 D Common Stock 2018-03-20 4 M 0 301 52.65 A 441 D Common Stock 2018-03-20 4 S 0 100 110.44 D 341 D Common Stock 2018-03-20 4 S 0 100 110.48 D 241 D Common Stock 2018-03-20 4 S 0 100 110.52 D 141 D Common Stock 2018-03-20 4 S 0 1 111.10 D 140 D Common Stock 683489 I By Trusts Stock Options 52.65 2018-03-19 4 M 0 21512 0 D 2009-12-31 2019-12-31 Common Stock 21512 301171 D Stock Options 52.65 2018-03-20 4 M 0 301 0 D 2009-12-31 2019-12-31 Common Stock 301 300870 D This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. This transaction was executed in multiple trades at prices ranging from $110.00 to $110.82. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $111.375 to $111.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ John S. Hess, Jr. under Power of Attorney 2018-03-21